NCT06011954 A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection Status RECRUITING Phase N/A
NCT05645692 A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05489211 Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Status RECRUITING Phase PHASE2
NCT05366725 A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy Status COMPLETED Phase N/A
NCT05279690 Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1
NCT05259696 Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) Status COMPLETED Phase PHASE1/PHASE2
NCT05233436 PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05219435 Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer Status COMPLETED Phase PHASE2
NCT05126433 Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE2
NCT05059522 Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04923178 A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies Status RECRUITING Phase N/A
NCT04501094 A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT04294277 Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery Status TERMINATED Phase PHASE2
NCT04235777 Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04223856 Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04180371 Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04152018 Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. Status TERMINATED Phase PHASE1
NCT04131634 Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer Status TERMINATED Phase PHASE2